In short, p16 is a multifunctional tumor suppressor capable of forming a negative regulatory loop with p53 and influencing the expression of a large number of cancer-associated genes both directly (e.g., RB, TP53) and indirectly by inhibiting the transcription regulators NF-κB and p53. Here, CDKN2A is linked to cancer.